↓ Skip to main content

Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition

Overview of attention for article published in Molecular Cancer, July 2010
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#3 of 1,902)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Citations

dimensions_citation
152 Dimensions

Readers on

mendeley
222 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition
Published in
Molecular Cancer, July 2010
DOI 10.1186/1476-4598-9-196
Pubmed ID
Authors

María M Caffarel, Clara Andradas, Emilia Mira, Eduardo Pérez-Gómez, Camilla Cerutti, Gema Moreno-Bueno, Juana M Flores, Isabel García-Real, José Palacios, Santos Mañes, Manuel Guzmán, Cristina Sánchez

X Demographics

X Demographics

The data shown below were collected from the profiles of 190 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 222 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 1%
United Kingdom 2 <1%
South Africa 1 <1%
Brazil 1 <1%
Unknown 215 97%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 42 19%
Researcher 35 16%
Student > Ph. D. Student 28 13%
Student > Master 25 11%
Other 18 8%
Other 34 15%
Unknown 40 18%
Readers by discipline Count As %
Agricultural and Biological Sciences 43 19%
Biochemistry, Genetics and Molecular Biology 39 18%
Medicine and Dentistry 30 14%
Pharmacology, Toxicology and Pharmaceutical Science 12 5%
Psychology 8 4%
Other 38 17%
Unknown 52 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 420. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 January 2024.
All research outputs
#68,353
of 25,257,066 outputs
Outputs from Molecular Cancer
#3
of 1,902 outputs
Outputs of similar age
#122
of 101,859 outputs
Outputs of similar age from Molecular Cancer
#1
of 26 outputs
Altmetric has tracked 25,257,066 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,902 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.8. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 101,859 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 26 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.